Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COP-RCT: Cessation of Pharmacotherapy in Recovered Chemotherapy-Induced Cardiotoxicity
jRCT1030230265Not yet recruiting
- Sponsor
- The University of Sydney
- Start
- Jul 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of carvedilol in chemotherapy-induced cardiotoxicity (CIC) and heart failure (HF) (2 arms), sponsored by The University of Sydney. Primary endpoint: Change in LVEF by cardiac MRI at 6 months. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
carvedilol
03
Conditions
chemotherapy-induced cardiotoxicity (CIC)heart failure (HF)
Beyond the preview
Go deeper on jRCT1030230265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030230265.